Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AVITA Medical (RCEL) Operating Expenses (2018 - 2025)

AVITA Medical filings provide 8 years of Operating Expenses readings, the most recent being $24.7 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 5.23% to $24.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $101.4 million, a 9.3% decrease, with the full-year FY2025 number at $101.4 million, down 9.31% from a year prior.
  • Operating Expenses hit $24.7 million in Q4 2025 for AVITA Medical, up from $23.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $30.2 million in Q3 2024 to a low of $12.3 million in Q3 2021.
  • Median Operating Expenses over the past 5 years was $22.1 million (2023), compared with a mean of $21.3 million.
  • Biggest five-year swings in Operating Expenses: plummeted 32.95% in 2021 and later skyrocketed 64.41% in 2023.
  • AVITA Medical's Operating Expenses stood at $12.3 million in 2021, then grew by 22.74% to $15.0 million in 2022, then skyrocketed by 64.41% to $24.7 million in 2023, then grew by 5.47% to $26.1 million in 2024, then fell by 5.23% to $24.7 million in 2025.
  • The last three reported values for Operating Expenses were $24.7 million (Q4 2025), $23.0 million (Q3 2025), and $26.1 million (Q2 2025) per Business Quant data.